Related references
Note: Only part of the references are listed.Current and future strategies for the treatment of chronic hepatitis C
Omar Alshuwaykh et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2021)
Treatment failure with DAA therapy: Importance of resistance
Christoph Sarrazin
JOURNAL OF HEPATOLOGY (2021)
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan
Chi-Yi Chen et al.
LIVER INTERNATIONAL (2021)
Prevalence, Awareness, and Treatment of Hepatitis C Virus Infection in South Korea: Evidence from the Korea National Health and Nutrition Examination Survey
Kyung-Ah Kim et al.
GUT AND LIVER (2020)
Real-Life Effectiveness and Safety of Sofosbuvir-Based Therapy in Genotype 2 Chronic Hepatitis C Patients in South Korea, with Emphasis on the Ribavirin Dose
Eun Sun Jang et al.
GUT AND LIVER (2020)
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
HEPATOLOGY (2020)
Viral and host factors are associated with retreatment failure in hepatitis C patients receiving all-oral direct antiviral therapy
Seiichi Mawatari et al.
HEPATOLOGY RESEARCH (2020)
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols
Valeria Caputo et al.
VIROLOGY JOURNAL (2020)
Technical Validation of a Hepatitis C Virus Whole Genome Sequencing Assay for Detection of Genotype and Antiviral Resistance in the Clinical Pathway
Carmen F. Manso et al.
FRONTIERS IN MICROBIOLOGY (2020)
Efficacy and Safety of Glecaprevir/Pibrentasvir in HCV Patients With Previous Direct-Acting Antiviral Therapy Failures: A Meta-Analysis
Chao Shen et al.
FRONTIERS IN MEDICINE (2020)
Clinical outcomes after the introduction of direct antiviral agents for patients infected with genotype 1b hepatitis C virus depending on the regimens: A multicenter study in Korea
Jung Hyun Kwon et al.
JOURNAL OF MEDICAL VIROLOGY (2019)
The change in the nationwide seroprevalence of hepatitis C virus and the status of linkage to care in South Korea from 2009 to 2015
Eun Sun Jang et al.
HEPATOLOGY INTERNATIONAL (2019)
Real-life effectiveness and safety of the daclatasvir/asunaprevir combination therapy for genotype 1b chronic hepatitis C patients: An emphasis on the pretreatment NS5A resistance-associated substitution test
Eun Sun Jang et al.
JOURNAL OF MEDICAL VIROLOGY (2019)
Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges
Thomas F. Baumert et al.
GASTROENTEROLOGY (2019)
Systematic review with meta-analysis: effectiveness and tolerability of interferon-free direct-acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia
F. Ji et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
The co-existence of NS5A and NS5B resistance-associated substitutions is associated with virologic failure in Hepatitis C Virus genotype 1 patients treated with sofosbuvir and ledipasvir
Seiichi Mawatari et al.
PLOS ONE (2018)
Pooled Resistance Analysis in Patients with Hepatitis C Virus Genotype 1 to 6 Infection Treated with Glecaprevir-Pibrentasvir in Phase 2 and 3 Clinical Trials
Preethi Krishnan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals
Stacey B. Prenner et al.
JOURNAL OF HEPATOLOGY (2017)
Real-life prevalence of resistance-associated variants against non-structural protein 5A inhibitors and efficiency of Daclatasvir plus Asunaprevir therapy in Korean patients with genotype 1b hepatitis C
Jung Hwan Yu et al.
VIROLOGY JOURNAL (2017)
Naturally occurring resistance mutations within the core and NS5B regions in hepatitis C genotypes, particularly genotype 5a, in South Africa
N. Prabdial-Sing et al.
ANTIVIRAL RESEARCH (2016)
Naturally occurring HCV NS5A/B inhibitor resistance-associated mutations to direct-acting antivirals
Linh Thuy Nguyen et al.
ANTIVIRAL THERAPY (2016)
KASL clinical practice guidelines: management of hepatitis C
Sook-Hyang Jeong et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2016)
Sambamba: fast processing of NGS alignment formats
Artem Tarasov et al.
BIOINFORMATICS (2015)
Infrequent Development of Resistance in Genotype 1-6 Hepatitis C Virus-Infected Subjects Treated With Sofosbuvir in Phase 2 and 3 Clinical Trials
Evguenia S. Svarovskaia et al.
CLINICAL INFECTIOUS DISEASES (2014)
Sofosbuvir: A Review of its Use in Patients with Chronic Hepatitis C
Gillian M. Keating
DRUGS (2014)
De novo assembly of highly diverse viral populations
Xiao Yang et al.
BMC GENOMICS (2012)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
New kinetic models for the hepatitis C virus
AS Perelson et al.
HEPATOLOGY (2005)
Share Paper
